Mar 5 |
Why Quoin Pharmaceuticals (QNRX) Shares Are Nosediving
|
Mar 5 |
QNRX: Potential Pool of Study Participants Expands; Financial Position Strengths
|
Mar 5 |
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
|
Mar 4 |
Quoin stock soars 60% on FDA update for ichthyosis drug
|
Mar 4 |
Why Quoin Pharmaceutical Stock Is Soaring
|
Mar 4 |
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
|
Feb 12 |
Quoin Pharmaceuticals files to sell 2.09M shares, warrants
|
Feb 8 |
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
|
Dec 13 |
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
|